Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy BiomarkersLisa H. Butterfield, Mary L. Disis, Peter P. Lee et al.|Clinical Cancer Research|2011Cited by 109
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory responseFernanda I. Arnaldez, Paolo A. Ascierto, Steven O’Day et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 93
Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancerSebastian Marwitz, Bernard A. Fox|Journal for ImmunoTherapy of Cancer|2021Cited by 26
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Bernard A. Fox|OncoImmunology|2018Cited by 5